Novartis Ag (NVS)

Although it’s one of the major pharmaceuticals, Novartis didn’t directly jump into the vaccine race. That might have been the best move for Novartis stock.

This Company is the Landlord of Life Sciences

By Neil George, Editor, Profitable Investing Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

This Stock Points to the Massive China Biotech Trend

By Matt McCall, Editor, MoneyWire Apr 23, 2020

There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.

These 4 Stocks to Sell Are Melting Down Now

By William Roth, InvestorPlace Market Strategist Feb 26, 2020

These blue-chip names are stocks to sell now as the coronavirus continues its rapid spread around the world.

3 Great Healthcare Stocks to Buy Right Now

By David Moadel, InvestorPlace Contributor Jan 28, 2020

The sector is a safe bet for long-term growth, but which health-care stocks stand to gain the most? Here are three picks to consider today.

Stock Market Today: Merger Monday; Tesla’s Cybertruck Pre-Orders

By Bret Kenwell, InvestorPlace Contributor Nov 25, 2019

Tesla hit 200,000 pre-orders and there was a bevy of M&A to report. Here's what happened in the stock market today.

The Medicines Company News: MDCO Stock Rockets 22% on Novartis Deal

By William White, InvestorPlace Writer Nov 25, 2019

The Medicines Company (MDCO) news for Monday about a $9.70 billion deal with Novartis (NVS) has MDCO stock heading higher.

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

By Chris Lau, InvestorPlace Contributor Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

10 Great Biotech Stocks to Buy in Q4

By Sarah Smith, Editor, Today's Market Oct 7, 2019

With FDA Breakthrough Therapy designations and robust drug pipelines, these biotech companies are all stocks to buy for 2020.

3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector

By Louis Navellier, Editor, Growth Investor Sep 14, 2019

When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).

10 Smart Dividend Stocks for the Rest of the Year

By James Brumley, InvestorPlace Feature Writer Jun 11, 2019

Ford, Verizon and AbbVie are just a trio of the top dividend stocks to buy for the remainder of 2019, particularly if the broad market hits turbulence.

New Sanofi CEO 2019: 8 Things to Know About Paul Hudson

By William White, InvestorPlace Writer Jun 7, 2019

There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.

Continued Smart M&A Moves Will Help Canopy Stock Break Out

By Luce Emerson, InvestorPlace Contributor Jun 5, 2019

Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.